Illumina Body Map 2 (GSE30611)
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr17_-_50201618 Show fit | 8.43 |
ENST00000225964.10
|
collagen type I alpha 1 chain |
|
chr2_+_188974364 Show fit | 8.28 |
ENST00000304636.9
ENST00000317840.9 |
collagen type III alpha 1 chain |
|
chr7_+_94394886 Show fit | 7.30 |
ENST00000297268.11
ENST00000620463.1 |
collagen type I alpha 2 chain |
|
chr19_+_47713412 Show fit | 6.51 |
ENST00000538399.1
ENST00000263277.8 |
EH domain containing 2 |
|
chr16_+_55479188 Show fit | 5.99 |
ENST00000219070.9
|
matrix metallopeptidase 2 |
|
chr9_+_98943898 Show fit | 5.44 |
ENST00000375001.8
|
collagen type XV alpha 1 chain |
|
chr9_+_134641768 Show fit | 5.34 |
ENST00000371817.8
ENST00000618395.4 |
collagen type V alpha 1 chain |
|
chr17_-_42423246 Show fit | 5.33 |
ENST00000357037.6
|
caveolae associated protein 1 |
|
chr13_+_110307276 Show fit | 5.14 |
ENST00000360467.7
ENST00000650540.1 |
collagen type IV alpha 2 chain |
|
chr2_-_1744442 Show fit | 4.91 |
ENST00000433670.5
ENST00000425171.1 ENST00000252804.9 |
peroxidasin |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 23.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
3.0 | 12.1 | GO:0044691 | tooth eruption(GO:0044691) |
2.5 | 9.9 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.9 | 8.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.5 | 7.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 7.0 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.8 | 6.9 | GO:2001137 | positive regulation of endocytic recycling(GO:2001137) |
1.4 | 6.8 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
0.9 | 6.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.7 | 6.0 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 33.9 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 18.9 | GO:0005901 | caveola(GO:0005901) |
0.9 | 15.8 | GO:0098651 | basement membrane collagen trimer(GO:0098651) |
5.2 | 15.7 | GO:0005584 | collagen type I trimer(GO:0005584) |
3.2 | 12.9 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.0 | 11.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 10.4 | GO:0005925 | focal adhesion(GO:0005925) |
0.9 | 9.3 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.3 | 6.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 6.0 | GO:0043202 | lysosomal lumen(GO:0043202) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 37.1 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.2 | 29.3 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 18.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 9.3 | GO:0005178 | integrin binding(GO:0005178) |
0.9 | 8.7 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.0 | 7.5 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 6.3 | GO:0008201 | heparin binding(GO:0008201) |
1.3 | 5.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 4.9 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.2 | 3.9 | GO:0016018 | cyclosporin A binding(GO:0016018) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 60.2 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 27.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 17.7 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 9.8 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 7.7 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 6.1 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 5.6 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 4.7 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 4.6 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 3.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 51.7 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.8 | 17.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 7.8 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 6.1 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.2 | 6.0 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 5.3 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.3 | 5.0 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 4.9 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 3.7 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 3.7 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |